Introduction {#s1}
============

Recovery from serious neurological injury requires substantial rewiring of neural circuits. Many methods have been developed to enhance synaptic plasticity in hopes of enhancing recovery. Unfortunately, these methods have largely failed in the clinic likely due to the challenge of precisely targeting specific synapses and absence of testing in clinically-relevant models ([@bib51]; [@bib33]). Real-time control of neural activity provides a new avenue to promote synaptic plasticity in specific networks and restore function after injury ([@bib12]; [@bib40]; [@bib37]; [@bib18]).

Human and animal studies demonstrate that precisely timed vagus nerve stimulation (VNS) can improve recovery of sensory and motor function. VNS engages neuromodulatory networks and triggers release of pro-plasticity factors including norepinephrine, acetylcholine, serotonin, brain-derived neurotrophic factor, and fibroblast growth factor ([@bib24]; [@bib28]; [@bib27]). This in turn influences expression and phosphorylation of proteins associated with structural and synaptic plasticity, including *Arc*, CaMKII, TrkB, and glutamate receptors ([@bib1]; [@bib14]). Engagement of neuromodulatory networks activates a transient synaptic eligibility trace to support spike-timing-dependent plasticity (STDP) ([@bib25]), thus raising the prospect that closed-loop neuromodulatory strategies may provide a means to direct specific, long-lasting plasticity to enhance recovery after neurological injury. Indeed, in the absence of neurological damage, repeatedly pairing sensory or motor events with brief bursts of VNS yields robust plasticity in sensory or motor cortex that is specific to the paired experience ([@bib12]; [@bib27]). Moreover, the addition of VNS to rehabilitative training improves recovery in rodent models of unilateral brain injury and in chronic stroke patients, highlighting the clinical potential of closed-loop neuromodulatory strategies ([@bib24]; [@bib31]; [@bib44]; [@bib20]; [@bib10]).

We tested the hypothesis that closed-loop VNS (CLV) could be harnessed to enhance recovery after spinal cord injury (SCI). To do so, we developed a real-time closed-loop neuromodulation paradigm based on the synaptic eligibility trace to deliver VNS immediately after the most successful forelimb movements during motor rehabilitation. The strategy uses a control algorithm that adaptively scales stimulation threshold to trigger a brief 0.5 s train of VNS on trials in which pull forces fall within the top quintile of previous trials (Top 20% CLV; [Figure 1a,b](#fig1){ref-type="fig"}, and [Figure 1---figure supplement 1a](#fig1s1){ref-type="fig"}). To test the hypothesis that temporal precision is required for VNS-dependent effects, we employed a similar algorithm in which stimulation was delivered on the weakest quintile of trials (Bottom 20% CLV; [Figure 1b](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1g](#fig1s1){ref-type="fig"}). Both algorithms deliver the same amount of VNS during rehabilitative training, but Bottom 20% CLV results in a significant delay between VNS and the most successful trials.

![Precisely-timed closed-loop vagus nerve stimulation based on the synaptic eligibility trace enhances recovery after spinal cord injury.\
(**a**) Closed-loop neuromodulation to deliver vagus nerve stimulation to reinforce the most successful trials during rehabilitative training after SCI. (**b**) Top 20% CLV received a 0.5 s train of VNS on trials in which pull force falls within the highest quintile of previous pull forces. The Bottom 20% CLV group received VNS on trials in which pull force falls within the lowest quintile. Rehab alone performed equivalent rehabilitative training without VNS. Each circle represents peak pull force on an individual trial. Inset shows an animal performing the isometric pull task. See [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} for more detail. (**c**) Top 20% CLV significantly improves forelimb function after SCI compared to Bottom 20% CLV and Rehab alone, indicating that precisely-timed VNS enhances recovery. (**d,e**) Differences in the intensity of rehabilitative training or the amount of stimulations cannot account for improved recovery. A significant increase in recovery is observed with Top 20% CLV after correcting for number of trials and number of stimulations (ANCOVA, effect of group; number of trials: F\[1,1\]=11.89, p=0.0031; number of stimulations: F\[1,1\]=9.57, p=0.0066). Gray circles denote individual subjects. (**f**) CLV delivered within 2 s of successful trials increases recovery, whereas CLV separated 25 s from successful trials fails to yield substantial benefits. This time window is consistent with the synaptic eligibility trace hypothesis. Horizontal error bars for Top 20% CLV and Delayed Top 20% CLV are not visible because of their small size. In panel c, \*\*p\<0.01, \*p\<0.05 for t-tests across groups at each time point. The color of the asterisk denotes the group compared to Top 20% CLV. Error bars indicate S.E.M.](elife-32058-fig1){#fig1}

Results {#s2}
=======

To test whether CLV could improve recovery of motor function after SCI, rats were trained to perform an automated reach-and-grasp task measuring volitional forelimb strength ([Figure 1b](#fig1){ref-type="fig"}, [Video 1](#video1){ref-type="video"}) ([@bib22]). Once proficient, rats received a right unilateral impact at spinal level C6 to impair function of the trained forelimb and underwent implantation of a bipolar cuff electrode on the left cervical vagus nerve ([@bib16]). SCI resulted in a 77% reduction in volitional forelimb strength, consistent with paresis observed in many cervical SCI patients ([Figure 1c](#fig1){ref-type="fig"}, PRE v. Wk 8, Paired t-test, t(29) = 37.34, p=4.4×10^−26^, [Video 2](#video2){ref-type="video"}). Top 20% CLV substantially boosted recovery of volitional forelimb strength compared to equivalent rehabilitative training without CLV (Rehab alone), demonstrating that CLV enhances recovery of motor function after SCI ([Figure 1c](#fig1){ref-type="fig"}; Two-way repeated measures ANOVA, Interaction; F\[6,120\]=3.88, p=1.43×10^−3^; [Videos 3](#video3){ref-type="video"}--[4](#video4){ref-type="video"}). CLV resulted in lasting recovery after the cessation of stimulation after week 11, consistent with the notion that CLV restores function in critical motor networks (Top 20% CLV; Wk 11 v. Wk 12; Paired t-test, t(12) = −0.89, p=0.38). Despite equivalent rehabilitation and a comparable number of stimulations delivered during task performance ([Figure 1d,e](#fig1){ref-type="fig"}), Bottom 20% CLV resulted in substantially diminished recovery compared to Top 20% CLV ([Figure 1c](#fig1){ref-type="fig"}, Two-way repeated measures ANOVA, Interaction; F\[6,114\]=2.40, p=0.03, [Video 5](#video5){ref-type="video"}) and failed to improve forelimb strength compared to Rehab alone. Together, these findings demonstrate that closed-loop neuromodulation paired with the most successful movements during rehabilitation improves recovery of motor function after cervical SCI.

###### Forelimb motor performance prior to SCI.

Representative example of a rat performing the isometric pull task prior to lesion. Note that the rat is highly proficient and displays clear forelimb motor control. (A) The plot on the bottom left displays pull force applied to the handle on an individual trial. The green line indicates force threshold to trigger delivery of a reward pellet. Note that the threshold adaptively scales based on the median peak force of the ten antecedent trials. The triangle indicates peak pull force on a trial. (B) The plot on the bottom right shows performance over the course of the session. Each circle indicates peak force from an individual trial. Green circles indicate trials in which pull force exceeded the reward threshold. White circles indicate trials in which peak force did not exceed the reward threshold.

10.7554/eLife.32058.006

###### Forelimb motor performance after unilateral SCI.

Representative example of a rat performing the isometric pull task four weeks after unilateral SCI. The rat displays a notable reduction in peak pull force, consistent with forelimb paresis, and clear deficits in motor control. (A) The plot on the bottom left displays pull force applied to the handle on an individual trial. The green line indicates the adaptive-scaled force threshold to trigger delivery of a reward pellet. Note that the threshold adaptively scales based on the median peak force of the ten antecedent trials. The triangle indicates peak pull force on a trial. (B) The plot on the bottom right shows performance over the course of the session. Each circle indicates peak force from an individual trial. Green circles indicate trials in which pull force exceeded the reward threshold. White circles indicate trials in which peak force did not exceed the reward threshold.

10.7554/eLife.32058.007

###### Performance after Rehabilitation Alone.

Representative example of a unilateral SCI rat performing the isometric pull task at the conclusion of six weeks of rehabilitative training alone. Note the sustained impairments in forelimb pull force generation and motor control despite intensive rehabilitative training. (A) The plot on the bottom left displays pull force applied to the handle on an individual trial. The green line indicates the adaptive-scaled force threshold to trigger delivery of a reward pellet. Note that the threshold adaptively scales based on the median peak force of the ten antecedent trials. The triangle indicates peak pull force on a trial. (B) The plot on the bottom right shows performance over the course of the session. Each circle indicates peak force from an individual trial. Green circles indicate trials in which pull force exceeded the reward threshold. White circles indicate trials in which peak force did not exceed the reward threshold.

10.7554/eLife.32058.008

###### Performance after Top 20% CLV

Representative example of a unilateral SCI rat performing the isometric pull task at the conclusion of six weeks of Top 20% CLV therapy. Note the improvements in motor control and increase in forelimb pull force compared to after SCI. (A) The plot on the bottom left displays pull force applied to the handle on an individual trial. The green line indicates the adaptive-scaled force threshold to trigger delivery of a reward pellet. Note that the threshold adaptively scales based on the median peak force of the ten antecedent trials. The red line denotes the stimulation threshold based on the top 20% of peak pull force from the preceding 10 trials. Vertical red lines indicate VNS delivery when pull force exceeds the stimulation threshold. The triangle indicates peak pull force on a trial. (B) The plot on the bottom right shows performance over the course of the session. Each circle indicates peak force from an individual trial. Green circles indicate trials in which pull force exceeded the reward threshold. Green circles with a red border indicate trials on which VNS was delivered (the top 20% of trials). White circles indicate trials in which peak force did not exceed the reward threshold.

10.7554/eLife.32058.009

###### Performance after Bottom 20% CLV

Representative example of a unilateral SCI rat performing the isometric pull task at the conclusion of six weeks of Bottom 20% CLV therapy. Note the remaining deficits in forelimb weakness and reduced motor control compared to Top 20% CLV. (A) The plot on the bottom left displays pull force applied to the handle on an individual trial. The dashed line indicates the adaptive-scaled force threshold to trigger delivery of a reward pellet. Note that the threshold adaptively scales based on the median peak force of the ten antecedent trials. The red line denotes the stimulation threshold based on the bottom 20% of peak pull force from the preceding 10 trials. Vertical red lines indicate VNS delivery when pull force fails to exceed the stimulation threshold. The triangle indicates peak pull force on a trial. (B) The plot on the bottom right shows performance over the course of the session. Each circle indicates peak force from an individual trial. Green circles indicate trials in which pull force exceeded the reward threshold. White circles indicate trials in which peak force did not exceed the reward threshold. White circles with a red border indicate trials on which VNS was delivered (the bottom 20% of trials).

10.7554/eLife.32058.010

The synaptic eligibility trace theory posits that neuromodulatory reinforcement must occur within seconds after neural activity to drive plasticity ([@bib25]). To clarify how temporally precise CLV must be, a subset of rats received VNS delayed approximately 1.5 s after the top 50% most successful trials (Delayed Top 20% CLV, [Figure 1---figure supplement 1d](#fig1s1){ref-type="fig"}). This short delay resulted in comparable recovery to stimulation delivered immediately after a successful trial in the Top 20% CLV group ([Figure 1f](#fig1){ref-type="fig"}). Stimulation in the Bottom 20% CLV group was separated by 25 ± 5 s from the most successful trials and failed to drive substantial benefits ([Figure 1f](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1g](#fig1s1){ref-type="fig"}). This absence of enhanced recovery despite delivery of CLV may be attributed to either the long delay or greater variance in the timing between stimulation and the most successful trials. These findings support a temporal precision limit for CLV near 10 s, consistent with the synaptic eligibility trace hypothesis ([@bib25]).

To determine whether more pairings of VNS with successful trials would improve recovery, we utilized an adaptive algorithm in which VNS was delivered on at least the top 50% most successful trials, resulting in 2.5 times more stimulation pairings (Top 50% CLV, [Figure 1---figure supplement 1j](#fig1s1){ref-type="fig"}). Top 50% CLV substantially improved recovery of forelimb function compared to Rehab alone, which provides an independent confirmation that CLV enhances recovery after SCI ([Figure 2a](#fig2){ref-type="fig"}, Two-way repeated measures ANOVA, Interaction; F\[6,174\]=3.56, p=2.38×10^−3^). The rate and degree of recovery were comparable in the Top 50% CLV and the Top 20% CLV groups ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), suggesting that timing is more important than quantity of stimulation.

![CLV enhances plasticity in spared corticospinal networks and improves functional recovery after unilateral SCI.\
(**a**) Top 50% CLV significantly improved recovery of forelimb function compared to Rehab alone. Sustained recovery was observed on week 12 after the cessation of stimulation, indicating lasting benefits. (**b**) Unilateral SCI caused substantial damage to gray matter, rubrospinal, and propriospinal tracts in the right hemicord, while largely sparing the right corticospinal tract and the entirety of the left hemicord. (**c**) ICMS reveals that Top 50% CLV significantly increases the area of the forelimb motor cortex evoking rehabilitated grasping movements compared to Rehab alone (N = 6,6). (**d**) Retrograde transneuronal tracing with PRV-152 was performed to evaluated anatomical connectivity from the left motor cortex neurons, left red nucleus neurons, and right C3/4 propriospinal neurons to grasping muscles in the trained (right) forelimb. Top 50% CLV restores connectivity and results in a significant increase in labeled neurons in the motor cortex compared to Rehab alone (N = 5,6). No changes were observed in red nucleus or C3/4 propriospinal neurons. Black boxes indicate ROIs; gray dot indicates lesion epicenter; inset shows injected muscles. (**e**) CLV does not affect lesion size. In all panels, gray circles denote individual subjects. In all panels, \*\*\*p\<0.001, \*\*p\<0.01, \*p\<0.05 for t-tests across groups. Error bars indicate S.E.M.](elife-32058-fig2){#fig2}

Plasticity in remaining networks could be harnessed to support recovery after SCI ([@bib13]; [@bib36]). Unilateral SCI resulted in extensive damage to gray matter, rubrospinal pathways, and propriospinal pathways in the right hemicord while largely sparing the right dorsal corticospinal tract (CST) ([Figure 2b](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Thus, we used intracortical microstimulation to test the hypothesis that CLV enhances output from the corticospinal circuits to the impaired forelimb. CLV resulted in eight times more motor cortex sites that generated grasp movements in the impaired forelimb compared to Rehab alone ([Figure 2c](#fig2){ref-type="fig"} and [Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}, Unpaired t-test, t(10) = 2.28, p=0.04), providing the first evidence that CLV induces large-scale plasticity in corticospinal networks after neurological injury.

We next tested the hypothesis that CLV improves recovery by increasing synaptic connections within the motor network controlling grasping muscles of the forelimb. We injected the retrograde transsynaptic tracer pseudorabies virus (PRV-152) into flexor digitorum profundus and palmaris longus and counted labeled neurons six days later. CLV resulted in a five-fold increase in labeled neurons in motor cortex compared to Rehab alone ([Figure 2d](#fig2){ref-type="fig"} and [Figure 2---figure supplement 5](#fig2s5){ref-type="fig"}, Unpaired t-test, t(9) = 7.63, p*=*3.2×10^−5^). The magnitude of this increase in synaptic connectivity is comparable to the seven-fold increase in the number of motor cortex sites that produce grasp. CLV failed to increase neuronal labeling of spinal motor neurons, red nucleus neurons or propriospinal neurons ([Figure 2d](#fig2){ref-type="fig"}). Additionally, CLV did not influence lesion extent ([Figure 2e](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Together, these results are consistent with anatomical plasticity in the spared corticospinal network contributing to enhanced recovery when CLV is added to rehabilitative training after SCI ([Figure 3](#fig3){ref-type="fig"}).

![Schematic of CLV-dependent recovery after unilateral SCI.\
(**a**) After unilateral SCI, loss of motor out from rubrospinal and propriospinal networks results in forelimb paresis and impairments in motor control. (**b**) The addition of CLV provides temporally-precise feedback on the most successful trials to facilitate training-dependent plasticity in remaining motor networks. (**c**) The benefits of CLV persist after the cessation of closed-loop stimulation because connectivity in critical neural circuits has been restored.](elife-32058-fig3){#fig3}

The observation that CLV improves recovery and enhances functional and anatomical plasticity in corticospinal networks suggests that CLV may prove ineffective if the CST is destroyed. Given the severity and anatomical heterogeneity of damage observed in SCI patients ([@bib48]), such a finding would limit the clinical utility of CLV. We therefore evaluated motor recovery in a bilateral injury model that virtually eliminates the CST on both sides of the cord ([Figure 4b](#fig4){ref-type="fig"}). Despite profound damage, CLV more than doubled the degree of forelimb motor recovery compared to Rehab alone ([Figure 4a](#fig4){ref-type="fig"}, Two-way repeated measures ANOVA, Interaction; F\[6,144\]=5.29, p=7.62×10^−5^). The observation that CLV can improve recovery following bilateral SCI suggests CLV could be clinically useful. We hypothesized that CLV enhances recovery by promoting plasticity in the rubrospinal and propriospinal pathways, which were damaged, but not eliminated, by this injury ([Figure 4b](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Indeed, CLV doubled the number of labeled red nucleus neurons and C3/4 propriospinal neurons compared to Rehab alone ([Figure 3d](#fig3){ref-type="fig"} and [Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}, Unpaired t-test, Red Nucleus: t(4) = 3.89, p=0.018; Propriospinal: t(4) = 2.77, p=0.05). Consistent with the extensive damage to the corticospinal pathway, CLV had no effect on reorganization of motor cortex ([Figure 4c](#fig4){ref-type="fig"} and [Figure 4---figure supplement 4](#fig4s4){ref-type="fig"}, Unpaired t-test, t(12) = −0.13, p=0.90) and failed to increase the number of labeled neurons in the motor cortex ([Figure 3d](#fig3){ref-type="fig"}, Unpaired t-test, t(4) = 0.83, p=0.45). These results suggest that CLV is capable of supporting recovery following SCI by strengthening anatomical connectivity within remaining pathways ([Figure 4---figure supplement 5](#fig4s5){ref-type="fig"}).

![CLV enhances synaptic plasticity and recovery after bilateral SCI.\
(**a**) After bilateral SCI, Top 50% CLV substantially enhanced recovery of volitional forelimb strength compared to Rehab alone. Improved function was maintained on week 14 after the cessation of CLV, indicative of lasting recovery. (**b**) Bilateral SCI resulted in virtually complete bilateral ablation of the corticospinal tract and substantial damage to gray matter. The rubrospinal and propriospinal tracts were lesioned, but partially remaining. (**c**) Unlike after unilateral SCI, Top 50% CLV failed to increase the area of the motor cortex evoking rehabilitated grasping movements compared to Rehab alone (N = 7,7). (**d**) CLV significantly increased synaptic connectivity from the left red nucleus neurons and right C3/4 propriospinal neurons to grasping muscles compared to Rehab alone (N = 3,3). Black boxes indicate ROIs; gray dot indicates lesion epicenter; inset shows injected muscles. In all panels, gray circles denote individual subjects. In all panels, \*\*p\<0.01, \*p\<0.05,+*P* = 0.05 for t-tests across groups. Error bars indicate S.E.M.](elife-32058-fig4){#fig4}

Discussion {#s3}
==========

In this study, we developed a novel closed-loop neuromodulation strategy to make use of the high temporal precision of the synaptic eligibility trace. We demonstrate that activation of the vagus nerve improves recovery when reliably delivered within seconds of a successful movement, and we provide the first evidence that CLV enhances reorganization of synaptic connectivity in remaining networks in two non-overlapping models of SCI. The flexibility to promote reorganization in a range of pathways is a critical benefit of CLV, given the great heterogeneity in the etiology, location, and extent of damage present in SCI patients.

Classical studies by Skinner demonstrate that adaptive reinforcement of successive approximations, or shaping, drives behavior toward a desired response ([@bib49]). This principle has been adopted for use in rehabilitation, with the intention to reinforce successively better movements ([@bib53]). We made use of this concept by applying an adaptively-scaled stimulation threshold to deliver CLV with the most successful forelimb movements during rehabilitation. Enhanced recovery was observed only when CLV was paired with trials that approximated the desired outcome, highlight the importance of timing for closed-loop stimulation to shape behavioral outcomes and maximize recovery.

The magnitude of neuromodulatory activation elicited by an event is directly proportional to the surprise, or unpredictability, of the event ([@bib19]; [@bib26]; [@bib46]). This phenomenon is ascribed to reward prediction error ([@bib47]). Unsurprising events fail to activate neuromodulatory systems, and even rewarding events fail to trigger neuromodulator release if they are expected. We posit the predictability and accompanying tedium of long, frustrating rehabilitation and the minimal reinforcement of practicing a previously simple motor task blunts plasticity and limits recovery after SCI. The closed-loop neuromodulation strategy developed here circumvents this by artificially engaging neuromodulatory networks and providing a repeated, non-adapting reinforcing signal typically associated with surprising consequences ([@bib24]; [@bib28]; [@bib27]). CLV drives temporally-precise neuromodulatory release to convert the synaptic eligibility trace in neuronal networks that generate optimal motor control to long-lasting plasticity ([@bib25]).

CLV is a minimally-invasive, safe strategy to provide precisely-timed engagement of multiple neuromodulatory networks to boost plasticity during rehabilitation ([@bib24]). Preliminary results in chronic stroke and tinnitus patients highlight the clinical potential of CLV, while delivering less than 1% of the total FDA-approved amount of stimulation ([@bib10]; [@bib11]; [@bib5]). Moreover, the flexibility to deliver stimulation with a variety of rehabilitative exercises raises the possibility to design CLV-based to target motor dysfunction of the lower limbs, somatosensory loss, and bowel and bladder issues, all of which are prevalent in SCI patients. Delineation of the timing requirements and documentation of neuronal changes driven by CLV in this study provide a framework for development of this strategy for a range of neurological conditions, including stroke, peripheral nerve injury, and post-traumatic stress disorder ([@bib24]; [@bib35]).

Materials and methods {#s4}
=====================

  --------------------------------------------------------------------------------------------------
  Reagent type (species) or resource   Designation   Source or reference               Identifiers
  ------------------------------------ ------------- --------------------------------- -------------
  Pseudorabies Virus Bartha Strain\    PRV-152       NIH Center for Neuroanatomy\      PRV-152
  containing the CMV-EGFP reporter\                  with Neurotropic Viruses (CNNT)   
  cassette                                                                             

  --------------------------------------------------------------------------------------------------

Experimental Design {#s4-1}
-------------------

All procedures performed in the study were approved by the University of Texas at Dallas Institutional Animal Care and Use Committee (Protocols: 14--10 and 99--06). Adult female Sprague Dawley rats (N = 181) used in this study were housed one per cage (12 hr light/dark cycle). Twelve experimentally naïve rats were used for control experiments. One hundred and sixty-nine rats were trained to proficiency on the isometric pull task as in our previous studies ([@bib31]; [@bib44]; [@bib22]; [@bib50]; [@bib21]; [@bib23]; [@bib30]; [@bib43]; [@bib39]). Sample sizes were based estimated effect size determined in our initial pilot studies and are consistent with comparable previous studies. Trained rats were food restricted Monday-Friday to provide task motivation (*ad libitum* access to water). Because of the cage geometry, only the right forelimb can be used to reach the pull handle to trigger a food reward. After reaching task proficiency (85% success rate on ten consecutive sessions), rats received a unilateral contusive injury (N = 128) or bilateral contusive injury (N = 41) of the cervical spinal cord. After recovery, rats received a vagus nerve cuff electrode and resumed training on the isometric pull task. In addition to the food reward, rats were dynamically allocated to balanced groups to receive a brief burst of vagus nerve stimulation (VNS) on appropriate trials. Rehabilitative training, consisting of freely performing the task, continued for six weeks. No VNS was delivered in any group on the final week of rehabilitative training, to allow assessment of lasting effects of stimulation. Terminal motor cortex mapping or transsynaptic tracing experiments occurred the week following the end of therapy in a subset of unilateral (N = 23) and bilateral SCI rats (N = 20). Eighty-seven rats were excluded from the study due to mortality (N = 20), inability to perform the task after injury (N = 25), or VNS device failure (N = 42). Device failure included mechanical failure of the headmount or loss of stimulation efficacy, determined by a cuff impedance \>25 kΩ or by the absence of a reduction in blood oxygenation in response to a train of VNS while under anesthesia (described below). This is a standard method to evaluate VNS efficacy ([@bib34]; [@bib6]). Animals that failed to demonstrate a reliable drop in oxygen saturation at the end of therapy were excluded. Bilateral SCI rats were given two additional weeks of recovery time due to their larger spinal lesion and slower return to recumbency ([Figure 4---figure supplement 6](#fig4s6){ref-type="fig"}). Other than therapy start time (6 vs. 8 weeks post-SCI), all training and assessment was identical for unilateral and bilateral SCI rats. All source data indexed across animals can be found in [Supplementary file 1](#supp1){ref-type="supplementary-material"}--[4](#supp4){ref-type="supplementary-material"}.

Volitional forelimb Force Generation Assessment {#s4-2}
-----------------------------------------------

The isometric pull task is a fully automated and quantitative assay to measure multiple parameters of forelimb force generation and was performed similar to previous descriptions ([@bib31]; [@bib44]; [@bib22]; [@bib50]; [@bib21], [@bib23]; [@bib30]; [@bib43]; [@bib39]). Isometric pull training sessions consisted of two 30 min sessions (separated by at least 2 hr) five days per week. Experimenters were blind to treatment group at all times throughout behavioral testing. Early in training, rats were encouraged to interact with the pull handle by dispensing pellets (45 mg chocolate-flavored pellets, Bio-Serv; Flemington, NJ) when they approached or touched the lever. The pull handle was initially located inside the test chamber and then slowly retracted outside of the behavioral chamber to encourage reaching with the right paw. A trial was initiated when the rats exerted at least 10 g of force on the pull handle. A trial window of 2 s started after trial initiation where the animal could receive a reward by pulling with a force exceeding a reward threshold. The reward threshold was scaled adaptively based on the median peak force of the 10 preceding trials, with a fixed bounded minimum of 10 grams and maximum of 120 g based on previous studies ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) ([@bib16]; [@bib39]). Thus, rats received rewards on trials that exceeded either the median peak force from the previous 10 trials or 120 g. The reward threshold was set to 10 g for the first 10 trials of a training session and adaptive scaled for the remaining trials ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). This reward threshold paradigm was used for all groups at all timepoints during the study.

Rats were trained until they reached proficiency, defined as a 10 consecutive sessions in which greater than 85% of trials exceeded 120 g. After reaching isometric pull task proficiency, rats were given a cervical unilateral or bilateral SCI at spinal level C6. Post-injury baseline force generation assessment occurred on week six for unilateral SCI and week eight for bilateral contusion SCI and consisted of 2 × 30 min sessions per day across two consecutive days (POST; [Figures 1C](#fig1){ref-type="fig"} and [2A,](#fig2){ref-type="fig"} and [3A](#fig3){ref-type="fig"}). Random group assignment was used to determine which rats received VNS for the first 75% of group assignment decisions. To ensure well-balanced treatment groups, the final 25% of rats were assigned to groups based on their post-injury performance. Rehabilitative training continued for 6 weeks with VNS delivered when appropriate. MotoTrak Software (Vulintus, Inc.) was used to record and display experimental data during the performance of the isometric pull task similar to previous studies ([@bib22]; [@bib16]; [@bib50]; [@bib43]; [@bib38]). A microcontroller board (Vulintus, Inc.; Dallas Texas USA) sampled the force transducer every 10 ms and relayed information to the MotoTrak software for offline analysis. For rats receiving VNS, stimulation was triggered by the behavioral software on appropriate trails during rehabilitative training. Peak pull force (maximum force generated in a trial, g) was calculated for every rat for every week of behavior. A Two-way repeated measures ANOVA was used to compared peak pull forces in each treatment condition across time, followed by *post hoc* Bonferroni-corrected unpaired t-tests where appropriate ([Figures 1C](#fig1){ref-type="fig"}, [2A](#fig2){ref-type="fig"} and [4A](#fig4){ref-type="fig"}). Percent benefit over Rehab alone was calculated as the recovery of peak pull force after therapy normalized to the average recovery observed in the Rehab alone group ([Figure 1J](#fig1){ref-type="fig"}). The distribution of pull forces after injury is shown in [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}. Behavioral data for each week for all individual subjects is available in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

Cervical Spinal Cord Injury (SCI) Surgery {#s4-3}
-----------------------------------------

Experimenters were blind to the group of the rat during surgery. All surgeries were performed using aseptic technique under general anesthesia. Rats were anesthetized with ketamine (50 mg/kg), xylazine (20 mg/kg), and acepromazine (5 mg/kg) for all procedures (i.p.). Heart rate and blood oxygenation was monitored during surgery. After achieving isometric pull task proficiency, rats received either a right side (unilateral) or midline (bilateral) C6 spinal cord contusive impact using surgical technique from previous studies ([@bib16]). A right side or bilateral dorsal C5 laminectomy was performed for rats receiving a unilateral or bilateral SCI, respectively. The vertebral column was stabilized using spinal microforceps. For unilateral SCI, the right spinal hemicord was contused using the Infinite Horizon Impact Device with a force of 200 kilodynes and zero dwell time as previously reported (Precision Systems and Instrumentation, Lexington, KY; impactor tip diameter = 1.25 mm) ([@bib16]). For bilateral SCI rats, the midline of the spinal cord was contused with a force of 225 kilodynes and zero dwell time (impactor tip diameter = 2.5 mm). The skin overlying the exposed vertebrae was then closed in layers and the incised skin closed using surgical staples. All rats received buprenorphine (s.c., 0.03 mg/kg, 1 day post-op), enrofloxacin (s.c., 10 mg/kg, 3 days post-op) and Ringer's solution (s.c., 10 mL, 3 days post-op) immediately after surgery and continuing post-operatively. All rats were monitored daily for at least 1 week post-injury. We documented time to return to recumbency, defined as the return of the righting reflex and ability to self-feed, and plantar placement following SCI. After bilateral SCI, rats took significantly longer to return to recumbency and forepaw plantar placement compared to unilateral SCI rats ([Figure 4---figure supplement 6](#fig4s6){ref-type="fig"}). Therefore, bilateral SCI rats started therapy 2 weeks later. After injury, rats were hand fed twice daily and given Ringer's solution (s.c., 10 mL) for up to 1 week post-injury to maintain a healthy diet.

Vagus nerve stimulation cuff implantation surgery {#s4-4}
-------------------------------------------------

A two-channel connector headmount and vagus nerve stimulating cuff were implanted on post-injury week six for unilateral and week eight for bilateral SCI rats similar to previous studies ([@bib12]; [@bib31]; [@bib44]; [@bib20]; [@bib21]; [@bib23]; [@bib30]; [@bib29]; [@bib7]). Regardless of group assignment, all rats underwent implantation of the headmount and cuff. Stimulation of the left cervical branch of the vagus nerve was performed using low current levels to avoid cardiac effects ([@bib12]). Incised skin was closed using suture. All rats received enrofloxacin (s.c., 10 mg/kg) following surgery and as needed at the sign of infection. To confirm cuff functionality and proper placement, heart rate, respiration, and blood oxygenation saturation during VNS (0.8 mA, 30 Hz, 100 µs pulse width, 1--5 s train duration) were monitored under anesthesia via pulse oximetry after cuff implant and at the end of therapy. Animals that failed to demonstrate a reliable drop in oxygen saturation at the end of therapy were excluded. Stimulation under anesthesia briefly suppressed cardiopulmonary function and was not more severe or lower threshold in SCI rats compared to intact rats.

Vagus nerve stimulation parameters {#s4-5}
----------------------------------

VNS was triggered by the behavioral software during rehabilitative training based on the stimulation threshold for each group, similar to previous studies ([@bib31]; [@bib44]; [@bib21], [@bib23]; [@bib30]). Each stimulation train consisted of 16 × 100 µsec 0.8 mA biphasic pulses delivered at 30 Hz. An adaptive stimulation threshold specific to each CLV group was used to determine stimulation delivery during rehabilitative training ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). The stimulation threshold was adaptively scaled based on the 10 antecedent trials, with each group receiving VNS triggered on trials which fall into the appropriate range. Rats in the Top 20% CLV group (N = 13) received VNS on trials in which pull force exceeded the top quintile of the previous ten trials, with no minimum or maximum. In the majority of these subjects (N = 9), VNS was delivered immediately (\~50 msec) after pull force exceeded the stimulation threshold ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). No stimulation was delivered on the first 10 trials during a training session. In a different subset of subjects (Delayed Top 20% CLV, N = 4), VNS was delivered at the end of the 2 s trial window on trials in which exceeded the stimulation threshold, independent of the when the threshold was crossed ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}). These groups displayed comparable performance (Top 20% CLV v. Top 20% CLV Delay, Week 12, Unpaired t-test, p=0.78) and were thus combined for analysis in [Figure 1C--E](#fig1){ref-type="fig"}. Rats in the Bottom 20% CLV group (N = 8) received VNS on trials in which pull force failed to exceed the bottom quintile of the previous ten trials, with no minimum or maximum. VNS was delivered at the end of the 2 s trial window if pull force was below the threshold ([Figure 1---figure supplement 1G](#fig1s1){ref-type="fig"}). Rats in the Top 50% CLV group received VNS on trials that exceeded the median pull force of the previous 10 trials or exceeded 120 g. VNS was delivered immediately (\~50 msec) after pull force exceeded the stimulation threshold [Figure 1---figure supplement 1J](#fig1s1){ref-type="fig"}). No groups received VNS on the final week of rehabilitative training (Week 12 for unilateral and Week 14 for bilateral SCI) to assess effects lasting after the cessation of stimulation. These parameters do not cause discomfort and do not alter reaching behavior ([@bib27]; [@bib42]).

Intracortical Microstimulation Mapping {#s4-6}
--------------------------------------

Terminal intracortical microstimulation mapping (ICMS) of motor cortex was performed in a subset of unilateral SCI (Rehab alone, N = 6; Top 50% CLV, N = 6) and bilateral SCI (Rehab alone, N = 7; Top 50% CLV, N = 7) rats at the end of therapy. A group of uninjured rats were used for control (Naïve, N = 7). Rats were anesthetized with and injection (i.p.) of ketamine (50 mg/kg), xylazine (20 mg/kg), and acepromazine (5 mg/kg). A cisternal drain was performed to reduce ventricular pressure and cortical edema during mapping ([@bib27]; [@bib42]). A craniotomy was then performed to expose left motor cortex. Intracortical microstimulation (ICMS) was delivered in motor cortex at a depth of 1.75 mm using a low impedance tungsten microelectrode with an interpenetration resolution of 500 µm (100 kΩ -- 1 MΩ electrode impedance; FHC Inc., Bowdin, MD; biphasic ICMS at 333 Hz, 50 ms train duration, 200 µsec pulse width, 0--200 µA current). Mapping experiments were performed blinded with two experimenters similar to previous studies ([@bib27]; [@bib42]). The first experimenter positioned the electrode for ICMS and recorded movement data. The second experimenter, blind to the experimental group of the animal and electrode position, delivered ICMS and classified movements. Movement threshold was first defined. ICMS current was then increased by no more than 50% to facilitate movement classification using visual inspection. Movements were classified into the following categories similar to previous studies: vibrissae, neck, jaw, digit, wrist, elbow, shoulder, hindlimb and trunk ([@bib8]; [@bib15]). The cortical area (mm \[[@bib33]\]) and movement threshold (µA) for each movement category was calculated for each group ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"} and [Figure 4---figure supplement 4](#fig4s4){ref-type="fig"}). Based on the 500 µm inter-electrode spacing, each stimulation site eliciting a movement was counted as 0.25 mm^2^. Movement area and threshold was assessed using One-way ANOVA and unpaired t-tests. Data for all movement classifications for each subject is available in [Supplementary file 2](#supp2){ref-type="supplementary-material"}.

Pseudorabies virus retrograde transneuronal tracing {#s4-7}
---------------------------------------------------

Transsynaptic tracer injections using pseudorabies virus 152 (PRV-152) were performed in a subset of unilateral SCI (Rehab, n = 6; VNS + Rehab, n = 5) and bilateral SCI (Rehab, n = 3; VNS + Rehab, n = 3) rats following the respective end of therapy. A group of uninjured rats were used for control (Naïve, n = 5). PRV-152 was a generous gift from the lab of Dr. Lynn Enquist and colleagues at Princeton University and was grown using standard procedures ([@bib9]). An incision was made over the medial face of the radius and ulna of the trained limb to expose the forelimb grasping muscles flexor digitorum profundus and palmaris longus. 15 µL of PRV-152 (\~8.06 ± 0.49 x 10^8^ plaque-forming units) was injected into the belly of each muscle across three separate sites. The incision was then closed with non-absorbable suture. We conducted detailed pilot studies to determine the optimal time of viral infection to allow for layer five cortical labeling. At 5--5.5 days post-infection we observed little to no cortical labeling for injured or uninjured animals. At 6--6.5 days post-infection we observed consistent layer five cortical labeling across injured or uninjured animals. Therefore, 6--6.5 days was used as our PRV-152 infection duration for our transsynaptic tracing studies. Rats were anesthetized with sodium pentobarbital (50 mg/kg, i.p.) and transcardially perfused with 4% paraformaldehyde in 0.1 M PBS (pH 7.5) at 6--6.5 days after injection. The brain and spinal cord were removed. Spinal roots were kept for anatomical reference. Tissue was then post-fixed overnight and cryoprotected in 30% sucrose.

Quantification was limited to the spinal motor neurons, C3/4 cervical propriospinal neurons, red nucleus neurons, and cortical layer five neurons because these regions exhibited consistent labeling and were specifically related to our hypotheses. The whole neuraxis from the rostral tip of the forebrain to spinal level T3 was blocked and frozen at −80 C in Shandon M1 embedding matrix (Thermo Fisher Scientific; Waltham, MA). Coronal forebrain and midbrain sections were sliced and slide-mounted at 35 µm using a cryostat (from the rostral tip of forebrain to 13 mm caudal). Coronal spinal cord sections were sliced and slide mounted at 50 µm (from C4 -- T3). After coverslipping, slides were scanned and digitized using the NanoZoomer 2.0-HT Whole Slide Scanner (Hamamatsu Photonics; Japan). Tissue images were exported to a custom software program for cell counting (<https://github.com/davepruitt/PRV-Cell-Counting>; copy archived at <https://github.com/elifesciences-publications/PRV-Cell-Counting>). PRV-152 infected neurons expressed enhanced green fluorescent protein. PRV-152 neuron counts were made on every other forebrain and midbrain section (35 µm inter-slice interval) and every third spinal cord section (100 µm inter-slice interval). Experimenters performing analysis were blind to the group of each rat. Cortical neuron counts were restricted to layer 5 of sensorimotor cortex ([@bib4]). We defined motor cortex using standard anatomical reference ([@bib41]). Our ICMS mapping studies confirm that these regions contain the cortical forelimb sensorimotor circuitry. Red nucleus neuron counts were made using standard anatomical reference ([@bib41]). Propriospinal neuron counts were made from spinal level C3 -- C4 in Rexed lamina VI, VII, VIII and IX using standard anatomical reference similar to previous studies ([@bib52]; [@bib17]). Back-labeled putative spinal motor neurons were located in Rexed lamina IX and counted identical to previous studies ([@bib52]; [@bib17]). Sensorimotor cortex, red nucleus and cervical propriospinal neuron counts were normalized within rats to the number of putative spinal motor neurons in the lower cervical and upper thoracic spinal cord to control for any differences in injection efficacy. No differences in spinal neuron labeling were observed between CLV and Rehab alone ([Figures 2E](#fig2){ref-type="fig"} and [4E](#fig4){ref-type="fig"}). Sensorimotor cortex, red nucleus and putative spinal motor neuron counts were analyzed separately using unpaired t-tests. Data representing raw neuron counts in each ROI is available in [Figure 2---figure supplement 5](#fig2s5){ref-type="fig"}, [Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}, and [Supplementary file 3](#supp3){ref-type="supplementary-material"}.

Lesion Histology and Analysis {#s4-8}
-----------------------------

At the completion of experimental testing, rats were anesthetized with sodium pentobarbital (50 mg/kg, i.p.) and transcardially perfused with 4% paraformaldehyde in 0.1 M PBS (pH 7.5). The spinal cord was removed and spinal roots were kept for anatomical reference. Spinal tissue was then post-fixed overnight, cryoprotected in 30% sucrose for 48 hr, blocked and frozen at −80 C in Shandon M1 embedding matrix (Thermo Fisher Scientific; Waltham, MA). Spinal tissue was sliced at 50 µm using a cryostat, slide mounted and stained for Nissl (gray matter) and myelin (white matter) substance similar to previous studies ([@bib16]; [@bib15]). Photomicrographs were taken at 600 µm intervals to quantify gray and white matter lesion metrics using Image J. For unilateral SCI, the rostral and caudal extent of spinal gray and white matter damage was expressed as the percentage of spared gray and white matter of the right hemicord with respect to the left hemicord ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). For bilateral SCI rats, the rostral and caudal extent of spinal damage was expressed as the percentage of spared gray and white matter for each hemicord with respect to an unlesioned rostral and caudal tissue reference within animals ([@bib2]). Smallest and largest lesion areas were fitted to a schematic of spinal level C6 ([Figures 2E](#fig2){ref-type="fig"} and [3E](#fig3){ref-type="fig"}). To calculate damage to fiber tracts, two experimenters blind to group assignment evaluated the percentage of lesioned tissue to the dorsal corticospinal tract, dorsolateral corticospinal tract, ventral corticospinal tract, rubrospinal tract, propriospinal tract, and gray matter at the lesion epicenter. The dorsal, dorsolateral, and ventral corticospinal tracts were combined to calculate total CST damage based on the proportion of fibers in each tract ([@bib3]). Data representing the damage estimates is available in [Supplementary file 4](#supp4){ref-type="supplementary-material"}.

Data Availability {#s4-9}
-----------------

All source data supporting the findings of this study are available in the online version of the paper.
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###### Volitional Forelimb Strength Behavioral Data

The values in the table below represent the average peak pull force for all rats included in the study at each week during therapy. Empty cells correspond to weeks in which data was not collected, based on the design of the experiment. All rat IDs are consistent for individual subjects throughout [Supplementary file 1](#supp1){ref-type="supplementary-material"}--[4](#supp4){ref-type="supplementary-material"}.

10.7554/eLife.32058.026

###### Intracortical Microstimulation Data

The values in the table below represent the area of motor cortex in mm ([@bib33]) evoking movements in each of the categories. All rat IDs are consistent for individual subjects throughout [Supplementary file 1](#supp1){ref-type="supplementary-material"}--[4](#supp4){ref-type="supplementary-material"}.

10.7554/eLife.32058.027

###### Pseudorabies Virus Labeling Data

The values in the table below represent the total number of labelled eGFP+ neurons in each of the ROIs below. For rostrocaudal distribution of labeled neurons, see [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"} and [Figure 4---figure supplement 5](#fig4s5){ref-type="fig"}. All rat IDs are consistent for individual subjects throughout [Supplementary file 1](#supp1){ref-type="supplementary-material"}--[4](#supp4){ref-type="supplementary-material"}.

10.7554/eLife.32058.028

###### Lesion Metrics

The values in the table below represent the estimated percent damage to gray matter and white matter tracts. All rat IDs are consistent for individual subjects throughout [Supplementary file 1](#supp1){ref-type="supplementary-material"}--[4](#supp4){ref-type="supplementary-material"}.

10.7554/eLife.32058.029
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Decision letter

Johansen-Berg

Heidi

Reviewing Editor

University of Oxford

United Kingdom

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Closed-loop Neuroprosthesis Restores Network Connectivity and Motor Control after Spinal Cord Injury\" for consideration by *eLife*. Your article has been favorably evaluated by Richard Ivry (Senior Editor) and three reviewers, one of whom, Heidi Johansen-Berg (Reviewer \#1), is a member of our Board of Reviewing Editors. The following individual involved in review of your submission has agreed to reveal their identity: Reggie Edgerton (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This manuscript reports the use of closed-loop vagus nerve stimulation to improve motor recovery after spinal cord injury. Overall, the results are potentially very interesting and impactful. However, the reviewers are concerned that the data are over interpreted in places and some key methodological details are lacking.

Essential revisions:

1\) There were queries/concerns over the deliveries of reward. Some of the concerns may be cleared up as aspects of the methods are clarified. Specifically:

a\) Trial structure is very confusing. Looking at [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, it is not clear that reward was always given 50% of the time. For example, in G, reward appears to be given more frequently that 50%? Moving [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} to [Figure 1](#fig1){ref-type="fig"} with clear delineation of the trial structure, reward, etc. will help.

b\) One reviewer commented that it appears that rats received an adaptive reward schedule, such that forces above a threshold resulted in a food reward. Therefore -- top 20% pulls would be rewarded while bottom 20% pulls would not be rewarded. To what extent might this difference in reward contribute to results? The current interpretation is that the improved recovery for the top 20% group is due to selective stimulation of \'good\' rather than \'bad\' movements. However, it seems that the quality (force) of the movement is confounded by the reward. Perhaps if the bottom 20% movements had also been rewarded then equivalent recovery would have been seen in that group. Please clarify or else discuss this confound.

c\) Another reviewer commented that it did not seem that the 120g criteria was used during rehab (i.e. as opposed to healthy training). It appears that during rehab the animals got a reward even if they remained at low levels of force. Is that correct? What was the distribution of forces that typically made the top/bottom 20% during rehab? Did they attempt a less adaptive approach that required higher force levels?

2\) What period during rehab does [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} represent? It is interesting that animals seem to start at low values and then rapidly \'ramp up\' only with stimulation. In other words, example G appears to show an animal that does not ramp up rapidly without stimulation. Is there always an acute effect of VNS on the ability to ramp up to higher forces? Does the ability to generate higher forces during training explain the final sustained benefits?

3\) The results reported in [Figure 1F](#fig1){ref-type="fig"} are used to support the notion that timing is critical. This is because the 0 and 2s delays are clearly better than the 25 second delay. However, in addition to the 25s condition having a longer mean delay -- it is a much more variable delay (relative to the top 20% movements) as stimulation in this condition is not tied to the top 20% movement (but instead to the bottom 20% movements). Therefore there is confound between mean delay and variability of temporal coupling between movement and stimulation. I therefore suggest that interpretation of this result should be cautious. For example, the statement in the Discussion that \'We confirmed that activation of the vagus nerve must occur within seconds of a successful movement\' is not adequately supported by the data. The data show that precisely timed stimulation within 2 seconds is effective, and that imprecisely timed stimulation at \>20 seconds is not. That doesn\'t rule out the possibility that precisely timed stimulation at say 5 seconds may be effective.

4\) [Figure 1D, E](#fig1){ref-type="fig"} are shown to illustrate similar number of trials and stimulated trials in the two stimulation groups. Although I can see that these distributions are overlapping I would not describe them as \'matched\'. Trials and stimulations are reduced (albeit (presumably) not significantly so) in the bottom 20% group compared to the top 20% group. Demonstrating that these distributions don\'t\' significantly differ from each other does not rule out the possibility that differences in trial numbers may have contributed to between group effects. To take into account differences in trial numbers would require, for example, including trial number as a confound in an ANCOVA.

5\) It is great that the authors list the number of animals that were excluded (n=87); 87 is a rather large number. Please list more specifically why. How was device failure assessed?

10.7554/eLife.32058.032

Author response

> Essential revisions:
>
> 1\) There were queries/concerns over the deliveries of reward. Some of the concerns may be cleared up as aspects of the methods are clarified. Specifically:
>
> a\) Trial structure is very confusing. Looking at [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, it is not clear that reward was always given 50% of the time. For example, in G, reward appears to be given more frequently that 50%? Moving [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} to [Figure 1](#fig1){ref-type="fig"} with clear delineation of the trial structure, reward, etc. will help.

We agree that the description of the reward and stimulation thresholds would benefit from additional clarification. To determine reward delivery, we utilized an adaptive reward threshold such that animals received a reward if the peak pull force on a trial exceeded the peak pull force of highest 50% (i.e., the median) of the preceding 10 trials *or* if it exceeded a fixed 120 g threshold. As a result, rewards could be delivered more often than 50% of the time, provided animals could generate pull forces greater than 120 g. We have used this capped adaptive threshold scheme in previous studies (1-3) This reward threshold was used in all groups at all times during the study.

We have provided additional text in the Materials and methods section (subsection "Vagus nerve stimulation parameters") and legend for [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} to clarify reward thresholds. Additionally, we have added stimulation thresholds to [Figure 1B](#fig1){ref-type="fig"} as suggested to further illustrate the adaptive thresholding.

> b\) One reviewer commented that it appears that rats received an adaptive reward schedule, such that forces above a threshold resulted in a food reward. Therefore -- top 20% pulls would be rewarded while bottom 20% pulls would not be rewarded. To what extent might this difference in reward contribute to results? The current interpretation is that the improved recovery for the top 20% group is due to selective stimulation of \'good\' rather than \'bad\' movements. However, it seems that the quality (force) of the movement is confounded by the reward. Perhaps if the bottom 20% movements had also been rewarded then equivalent recovery would have been seen in that group. Please clarify or else discuss this confound.

The reviewer is correct in noting that an adaptive reward schedule was used. However, all groups received rewards based on the same capped adaptive reward threshold (described above). Thus, given that the reward schedule was identical across groups, reward delivery cannot account for the differences in recovery and plasticity observed across groups. We have now clarified the reward threshold in the Materials and methods section (subsection "Volitional Forelimb Force Generation Assessment") and the legend for [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}.

> c\) Another reviewer commented that it did not seem that the 120g criteria was used during rehab (i.e. as opposed to healthy training). It appears that during rehab the animals got a reward even if they remained at low levels of force. Is that correct? What was the distribution of forces that typically made the top/bottom 20% during rehab? Did they attempt a less adaptive approach that required higher force levels?

The same adaptive reward threshold was in all groups at all times throughout the study, both during pre-training and during rehab after SCI. The capped adaptive reward threshold was set such that animals received a reward if the peak pull force on a particular trial exceeded the median peak pull force of the preceding 10 trials or exceeded a fixed 120 g threshold. Prior to injury, all animals easily exceeded the 120 g threshold on most trials, thus the reward threshold was typically stable at 120 g. The reviewer is correct that animals could receive a reward for lower levels of force. After injury, because of the substantial deficit in forelimb strength, animals very rarely exceeded the 120 g threshold. Thus, the vast majority of their rewards were delivered on trials that exceed the median of their previous ten trials, but fall below the 120 g threshold.

In general, following SCI, the bottom 20% of trials had pull forces of \<16g, while pull force on the top 20% trials was \>58g. The distributions of pull forces were similar for the Top 20% CLV and Bottom 20% CLV groups at the beginning of therapy. We now include a figure showing the distribution of pull forces for these groups ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}).

We elected not to use a less adaptive approach, because our previous study demonstrated that fixed, static reward thresholds result in comparable performance, but a reduced number of trials, compared to an adaptive threshold (3). Therefore, in order to balance the number of trials performed across groups, we limited our study to use of the adaptive threshold.

> 2\) What period during rehab does [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} represent? It is interesting that animals seem to start at low values and then rapidly \'ramp up\' only with stimulation. In other words, example G appears to show an animal that does not ramp up rapidly without stimulation. Is there always an acute effect of VNS on the ability to ramp up to higher forces? Does the ability to generate higher forces during training explain the final sustained benefits?

All examples are taken from the last week of rehabilitative therapy. The apparent ramp up is due to way in which thresholds are calculated. In all groups, the first ten trials of a session are rewarded regardless of pull force to encourage animals to perform the task when placed in the training apparatus. The reward threshold then adaptively scales (as described above) after the first ten trials, typically requiring greater pull forces to receive a reward. Because greater pull forces are required, performance typically does increase over the first 10-20 trials. This affect is independent of stimulation, as it is observed both prior to lesion and during rehabilitative training in animals that do not receive VNS (Rehab Alone). To provide a more comparable illustration with the other groups, we have replaced panel G with a different example.

Our previous studies demonstrate that there is no acute effect of VNS on performance (4, 5). In this study, no differences in performance are observed across groups after a single session of VNS, suggesting an absence of an acute effect (Peak Pull Force; One-way ANOVA, F\[2,27\] = 0.38, *P* = 0.69). Moreover, there was no trend toward increased pull forces within a session, nor differences in within-session pull force changes comparing groups that received VNS and groups that did not, at any time during therapy (Slope of peak pull forces over a session; One-way ANOVA, F\[2,27\] = 1.96, *P* = 0.16). Together, these findings confirm that VNS does not acutely change performance.

> 3\) The results reported in [Figure 1F](#fig1){ref-type="fig"} are used to support the notion that timing is critical. This is because the 0 and 2s delays are clearly better than the 25 second delay. However, in addition to the 25s condition having a longer mean delay -- it is a much more variable delay (relative to the top 20% movements) as stimulation in this condition is not tied to the top 20% movement (but instead to the bottom 20% movements). Therefore there is confound between mean delay and variability of temporal coupling between movement and stimulation. I therefore suggest that interpretation of this result should be cautious. For example, the statement in the Discussion that \'We confirmed that activation of the vagus nerve must occur within seconds of a successful movement\' is not adequately supported by the data. The data show that precisely timed stimulation within 2 seconds is effective, and that imprecisely timed stimulation at \>20 seconds is not. That doesn\'t rule out the possibility that precisely timed stimulation at say 5 seconds may be effective.

We agree with the reviewer that the temporal variability may also contribute to the reduced recovery observed with Bottom 20% CLV. Changes to the text have been made to temper the conclusions as suggested (Results, second paragraph and Discussion, first paragraph).

> 4\) [Figure 1D, E](#fig1){ref-type="fig"} are shown to illustrate similar number of trials and stimulated trials in the two stimulation groups. Although I can see that these distributions are overlapping I would not describe them as \'matched\'. Trials and stimulations are reduced (albeit (presumably) not significantly so) in the bottom 20% group compared to the top 20% group. Demonstrating that these distributions don\'t\' significantly differ from each other does not rule out the possibility that differences in trial numbers may have contributed to between group effects. To take into account differences in trial numbers would require, for example, including trial number as a confound in an ANCOVA.

We agree with the reviewers that this qualification requires additional statistical support. We performed an ANCOVA on peak pull force and either trial number or stimulation number. After accounting for the number of trials, a significant group effect remains, consistent with the hypothesis that the number of trials cannot account for peak pull force (ANCOVA, effect of group: F\[1,1\] = 11.89, p = 0.0031). Similarly, a significant group effect on peak pull force remains after accounting for number of stimulations (ANCOVA, effect of group: F\[1,1\] = 9.57, p = 0.0066). We now include these statistical comparisons in the legend for [Figure 1](#fig1){ref-type="fig"}. Additionally, we have rephrased the statement to indicate that the groups performed a comparable, rather than matched, number of stimulations (Results, first paragraph).

> 5\) It is great that the authors list the number of animals that were excluded (n=87); 87 is a rather large number. Please list more specifically why. How was device failure assessed?

In an effort to increase the rigor and reproducibility of our studies, we have taken care to diligently report any dropouts and their associated causes, thus we appreciate the reviewers' recognition. The exclusion criteria match our previous studies (6-11). Given the large total number of animals in the study, the chronicity of the study, and the use of a neurostimulation device with associated failure modes, the 87 animals excluded is roughly equivalent to previous studies evaluating chronic recovery of motor function with VNS after neurological injury (6-10) We now provide more detail as to the specific reason for exclusion in the Materials and methods section (subsection "Experimental Design"). Additionally, we provide greater detail on the procedures used to assess device failure (subsection "Vagus nerve stimulation cuff implantation surgery").

References

1\) Ganzer, P. D. et al. Awake behaving electrophysiological correlates of forelimb hyperreflexia, weakness and disrupted muscular synchronization following cervical spinal cord injury in the rat. Behav. Brain Res. 307, 100--111 (2016).

2\) Meyers, E. C. et al. Median and ulnar nerve injuries reduce volitional forelimb strength in rats. Muscle Nerve (2017).

3\) Meyers, E. et al. The supination assessment task: An automated method for quantifying forelimb rotational function in rats. J. Neurosci. Methods 266, (2016).

4\) Hulsey, D. R. et al. Reorganization of Motor Cortex by Vagus Nerve Stimulation Requires Cholinergic Innervation. Brain Stimul. 9, (2016).

5\) Porter, B. A. et al. Repeatedly Pairing Vagus Nerve Stimulation with a Movement Reorganizes Primary Motor Cortex. Cereb. Cortex 22, 2365--2374 (2011).

6\) Khodaparast, N. et al. Vagus nerve stimulation during rehabilitative training improves forelimb strength following ischemic stroke. Neurobiol. Dis. 60, (2013).

7\) Khodaparast, N. et al. Vagus nerve stimulation delivered during motor rehabilitation improves recovery in a rat model of stroke. Neurorehabil. Neural Repair 28, 698--706 (2014).

8\) Hays, S. A. et al. Vagus nerve stimulation during rehabilitative training enhances recovery of forelimb function after ischemic stroke in aged rats. Neurobiol. Aging 43, (2016).

9\) Khodaparast, N. et al. Vagus Nerve Stimulation during Rehabilitative Training Improves Forelimb Recovery after Chronic Ischemic Stroke in Rats. Neurorehabil. Neural Repair 30, (2016).

10\) Pruitt, D. T. et al. Vagus Nerve Stimulation Delivered with Motor Training Enhances Recovery of Function after Traumatic Brain Injury. J. Neurotrauma 33, 871--879 (2016).

11\) Borland, M. S. et al. The Interval Between VNS-Tone Pairings Determines the Extent of Cortical Map Plasticity. Neuroscience (2017). doi:10.1016/j.neuroscience.2017.11.004
